Literature DB >> 22243776

FOXP3(+) regulatory and TIA-1(+) cytotoxic T lymphocytes in HIV-associated Hodgkin lymphoma.

Junichi Kiyasu1, Ryosuke Aoki, Paula Yurie Tanaka, Luis Fernando Pracchia, Edenilson Eduardo Calore, Nilda Maria Perez, Yoshizo Kimura, Daisuke Niino, Yasuo Sugita, Ryoichi Takayanagi, Yasunobu Abe, Masao Matsuoka, Koichi Ohshima.   

Abstract

Human immunodeficiency virus (HIV) infects CD4(+) lymphocytes, leading to a development of malignant lymphomas, such as HIV-associated Hodgkin Lymphoma (HIV-HL). This study aimed to assess the differences in cellular composition of the inflammatory reactive background of HIV-HLs. We examined infiltrating T lymphocytes, specifically regulatory T cells, cytotoxic cells, Epstein-Barr virus (EBV) related antigens and HIV-receptor CCR5. In all HIV-HL cases, Hodgkin and Reed-Sternberg (HRS) cells showed EBER1 expression, LMP-1 staining positivity and EBNA-2 staining negativity, except for one case which showed LMP-1 staining negativity. Our histological findings indicate the percentage of CD8(+) , TIA-1(+) lymphocytes was significantly higher in HIV-HL than in non-HIV-HL cases (P < 0.05). On the other hand, the percentage of CD4(+) , FOXP3(+) lymphocytes was significantly lower in HIV-HL than in non-HIV-HL cases (P < 0.05) but present. The percentage of CCR5(+) lymphocytes was significantly lower in HIV-HL than in non-HIV-HL cases (P < 0.05). Usually, CD4(+) and CCR5(+) lymphocytes are reported to be rarely detected in HIV-associated non-Hodgkin lymphomas, but the presence of CD4(+) and/or FOXP3(+) lymphocytes may be implicated in the pathogenesis of HL. In addition, although additional CD8(+) lymphocytes are probably not EBV-LMP specific cytotoxic T-cells, these lymphocytes may also well be involved in the pathogenesis of HIV-HL.
© 2011 The Authors. Pathology International © 2011 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22243776     DOI: 10.1111/j.1440-1827.2011.02754.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  4 in total

Review 1.  How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.

Authors:  Thomas S Uldrick; Richard F Little
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

Review 2.  [Lymph node pathology - an update].

Authors:  S Hartmann; M L Hansmann
Journal:  Pathologe       Date:  2013-02       Impact factor: 1.011

3.  CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients.

Authors:  Katherine Antel; D Chetty; J Oosthuizen; Z Mohamed; L Van der Vyver; E Verburgh
Journal:  Pathology       Date:  2021-02-06       Impact factor: 5.335

4.  Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells.

Authors:  Antonia Pavlovic; Merica Glavina Durdov; Vesna Capkun; Jasminka Jakelic Pitesa; Maja Bozic Sakic
Journal:  Med Sci Monit       Date:  2016-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.